Cargando…

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms

BACKGROUND: Animal studies suggest that brain apolipoprotein E (apoE) levels influence amyloid-β (Aβ) deposition and thus risk for Alzheimer's disease (AD). We have previously demonstrated that deletion of the ATP-binding cassette A1 transporter (ABCA1) in mice causes dramatic reductions in bra...

Descripción completa

Detalles Bibliográficos
Autores principales: Wahrle, Suzanne E, Shah, Aarti R, Fagan, Anne M, Smemo, Scott, Kauwe, John SK, Grupe, Andrew, Hinrichs, Anthony, Mayo, Kevin, Jiang, Hong, Thal, Leon J, Goate, Alison M, Holtzman, David M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857699/
https://www.ncbi.nlm.nih.gov/pubmed/17430597
http://dx.doi.org/10.1186/1750-1326-2-7
_version_ 1782133161505849344
author Wahrle, Suzanne E
Shah, Aarti R
Fagan, Anne M
Smemo, Scott
Kauwe, John SK
Grupe, Andrew
Hinrichs, Anthony
Mayo, Kevin
Jiang, Hong
Thal, Leon J
Goate, Alison M
Holtzman, David M
author_facet Wahrle, Suzanne E
Shah, Aarti R
Fagan, Anne M
Smemo, Scott
Kauwe, John SK
Grupe, Andrew
Hinrichs, Anthony
Mayo, Kevin
Jiang, Hong
Thal, Leon J
Goate, Alison M
Holtzman, David M
author_sort Wahrle, Suzanne E
collection PubMed
description BACKGROUND: Animal studies suggest that brain apolipoprotein E (apoE) levels influence amyloid-β (Aβ) deposition and thus risk for Alzheimer's disease (AD). We have previously demonstrated that deletion of the ATP-binding cassette A1 transporter (ABCA1) in mice causes dramatic reductions in brain and cerebrospinal fluid (CSF) apoE levels and lipidation. To examine whether polymorphisms in ABCA1 affect CSF apoE levels in humans, we measured apoE in CSF taken from 168 subjects who were 43 to 91 years old and were either cognitively normal or who had mild AD. We then genotyped the subjects for ten previously identified ABCA1 single nucleotide polymorphisms (SNPs). RESULTS: In all subjects, the mean CSF apoE level was 9.09 μg/ml with a standard deviation of 2.70 μg/ml. Levels of apoE in CSF samples taken from the same individual two weeks apart were strongly correlated (r(2 )= 0.93, p < 0.01). In contrast, CSF apoE levels in different individuals varied widely (coefficient of variation = 46%). CSF apoE levels did not vary according to AD status, APOE genotype, gender or race. Average apoE levels increased with age by ~0.5 μg/ml per 10 years (r(2 )= 0.05, p = 0.003). We found no significant associations between CSF apoE levels and the ten ABCA1 SNPs we genotyped. Moreover, in a separate sample of 1225 AD cases and 1431 controls, we found no association between the ABCA1 SNP rs2230806 and AD as has been previously reported. CONCLUSION: We found that CSF apoE levels vary widely between individuals, but are stable within individuals over a two-week interval. AD status, APOE genotype, gender and race do not affect CSF apoE levels, but average CSF apoE levels increase with age. Given the lack of association between CSF apoE levels and genotypes for the ABCA1 SNPs we examined, either these SNPs do not affect ABCA1 function or if they do, they do not have strong effects in the CNS. Finally, we find no evidence for an association between the ABCA1 SNP rs2230806 and AD in a large sample set.
format Text
id pubmed-1857699
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18576992007-04-27 Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms Wahrle, Suzanne E Shah, Aarti R Fagan, Anne M Smemo, Scott Kauwe, John SK Grupe, Andrew Hinrichs, Anthony Mayo, Kevin Jiang, Hong Thal, Leon J Goate, Alison M Holtzman, David M Mol Neurodegener Research Article BACKGROUND: Animal studies suggest that brain apolipoprotein E (apoE) levels influence amyloid-β (Aβ) deposition and thus risk for Alzheimer's disease (AD). We have previously demonstrated that deletion of the ATP-binding cassette A1 transporter (ABCA1) in mice causes dramatic reductions in brain and cerebrospinal fluid (CSF) apoE levels and lipidation. To examine whether polymorphisms in ABCA1 affect CSF apoE levels in humans, we measured apoE in CSF taken from 168 subjects who were 43 to 91 years old and were either cognitively normal or who had mild AD. We then genotyped the subjects for ten previously identified ABCA1 single nucleotide polymorphisms (SNPs). RESULTS: In all subjects, the mean CSF apoE level was 9.09 μg/ml with a standard deviation of 2.70 μg/ml. Levels of apoE in CSF samples taken from the same individual two weeks apart were strongly correlated (r(2 )= 0.93, p < 0.01). In contrast, CSF apoE levels in different individuals varied widely (coefficient of variation = 46%). CSF apoE levels did not vary according to AD status, APOE genotype, gender or race. Average apoE levels increased with age by ~0.5 μg/ml per 10 years (r(2 )= 0.05, p = 0.003). We found no significant associations between CSF apoE levels and the ten ABCA1 SNPs we genotyped. Moreover, in a separate sample of 1225 AD cases and 1431 controls, we found no association between the ABCA1 SNP rs2230806 and AD as has been previously reported. CONCLUSION: We found that CSF apoE levels vary widely between individuals, but are stable within individuals over a two-week interval. AD status, APOE genotype, gender and race do not affect CSF apoE levels, but average CSF apoE levels increase with age. Given the lack of association between CSF apoE levels and genotypes for the ABCA1 SNPs we examined, either these SNPs do not affect ABCA1 function or if they do, they do not have strong effects in the CNS. Finally, we find no evidence for an association between the ABCA1 SNP rs2230806 and AD in a large sample set. BioMed Central 2007-04-12 /pmc/articles/PMC1857699/ /pubmed/17430597 http://dx.doi.org/10.1186/1750-1326-2-7 Text en Copyright © 2007 Wahrle et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wahrle, Suzanne E
Shah, Aarti R
Fagan, Anne M
Smemo, Scott
Kauwe, John SK
Grupe, Andrew
Hinrichs, Anthony
Mayo, Kevin
Jiang, Hong
Thal, Leon J
Goate, Alison M
Holtzman, David M
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms
title Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms
title_full Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms
title_fullStr Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms
title_full_unstemmed Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms
title_short Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms
title_sort apolipoprotein e levels in cerebrospinal fluid and the effects of abca1 polymorphisms
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857699/
https://www.ncbi.nlm.nih.gov/pubmed/17430597
http://dx.doi.org/10.1186/1750-1326-2-7
work_keys_str_mv AT wahrlesuzannee apolipoproteinelevelsincerebrospinalfluidandtheeffectsofabca1polymorphisms
AT shahaartir apolipoproteinelevelsincerebrospinalfluidandtheeffectsofabca1polymorphisms
AT faganannem apolipoproteinelevelsincerebrospinalfluidandtheeffectsofabca1polymorphisms
AT smemoscott apolipoproteinelevelsincerebrospinalfluidandtheeffectsofabca1polymorphisms
AT kauwejohnsk apolipoproteinelevelsincerebrospinalfluidandtheeffectsofabca1polymorphisms
AT grupeandrew apolipoproteinelevelsincerebrospinalfluidandtheeffectsofabca1polymorphisms
AT hinrichsanthony apolipoproteinelevelsincerebrospinalfluidandtheeffectsofabca1polymorphisms
AT mayokevin apolipoproteinelevelsincerebrospinalfluidandtheeffectsofabca1polymorphisms
AT jianghong apolipoproteinelevelsincerebrospinalfluidandtheeffectsofabca1polymorphisms
AT thalleonj apolipoproteinelevelsincerebrospinalfluidandtheeffectsofabca1polymorphisms
AT goatealisonm apolipoproteinelevelsincerebrospinalfluidandtheeffectsofabca1polymorphisms
AT holtzmandavidm apolipoproteinelevelsincerebrospinalfluidandtheeffectsofabca1polymorphisms